Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02461446 · ClinicalTrials.gov registry record

Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations

A clinical trial of Autism and ASD, sponsored by Boston Children's Hospital.

Recruiting
Registry status
170
Enrollment target
5
Study locations

NCT02461446 is a study of Autism and ASD that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 170 participants, roughly in line with the 182-participant average among 104 other Autism trials with a reported enrollment target. The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02461446, a study of Autism and ASD, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
170 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to determine cross-sectional and longitudinal medical, behavioral, and cognitive differences between PTEN ASD and other groups, as well as to identify cognitive, neural systems, and molecular biomarkers specific to PTEN ASD. In addition, this study will be creating and maintaining a biorepository and linked phenotypic database for PTEN ASD.

Study Locations (5)

California

  • University of California at Los Angeles - Los Angeles
  • Stanford University Medical Center - Stanford

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati
  • Cleveland Clinic - Cleveland

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2015-05
Est. Completion 2026-12

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT02461446

The ClinicalTrials.gov registry entry for NCT02461446 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 182-participant average among 104 other Autism trials with a reported enrollment target. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Autism appearing as the primary indexed condition, and to 0 interventions.

NCT02461446 reports 5 study locations spanning 3 distinct geographic areas - top geographies include California, Ohio, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02461446 about?

NCT02461446 is a clinical study titled "Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations". The purpose of this study is to determine cross-sectional and longitudinal medical, behavioral, and cognitive differences between PTEN ASD and other groups, as well as to identify cognitive, neural systems, and molecular biomarkers specific to PTEN ASD. In addition, this study will be creating and m...

What is the current status of trial NCT02461446?

This trial is currently recruiting. The enrollment target is 170 participants. The study started on 2015-05. Estimated completion is 2026-12.

What conditions does trial NCT02461446 study?

This clinical trial studies the following conditions: Autism, ASD, PTEN Hamartoma Tumor Syndrome, PTEN, Macrocephaly.

Who is sponsoring clinical trial NCT02461446?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02461446 being conducted?

This trial has 5 study locations across California, Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.